Clinical Trial Update: Refining MDR-TB Treatment (T) Regimens (R) for Ultra(U) Short(S) Therapy(T)-PLUS [NA]

View source ↗

Summary

A completed clinical trial evaluating refined ultra-short regimens for treating multidrug-resistant tuberculosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multidrug-resistant Tuberculosis

Snippet

Sponsor: Huashan Hospital | Conditions: Multidrug Resistant Tuberculosis | NA | Status: COMPLETED